HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk

Erlich, Henry, Valdes, Ana Maria, Noble, Janelle, Carlson, Joyce A., Varney, Mike, Concannon, Pat, Mychaleckyj, Josyf C., Todd, John A. +6 more·2008·Diabetes
DOI 10.2337/db07-1331

Cited by (694)

Items 101–200 of 694

  1. Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention
    Aaron W. Michels, Li Zhang, Anmar Khadra, Jake A. Kushner, MARIA JOSE REDONDO, Massimo Pietropaolo · 2015 · Pediatric Diabetes
  2. Novel antigens in type 1 diabetes: The importance of ZnT8
    Janet M. Wenzlau, Lisa M. Frisch, Thomas J. Gardner, Suparna A. Sarkar, John C. Hutton, Howard W. Davidson · 2009 · Current Diabetes Reports
  3. Genetic background of multiple sclerosis.
    A. D. Sadovnick · 2012 · Autoimmunity Reviews
  4. Multiple loci in the HLA complex are associated with Addison's disease.
    Beate Skinningsrud, B. Lie, Ewa H. Lavant, J. Carlson, H. Erlich, H. Akselsen, K. Gervin, A. B. Wolff, Martina M. Erichsen, K. Løvås et al. · 2011 · Journal of Clinical Endocrinology and Metabolism
  5. The genetics of chronic inflammatory diseases.
    G. Heap, D. V. van Heel · 2009 · Human Molecular Genetics
  6. HLA Class II Genotyping of African American Type 1 Diabetic Patients Reveals Associations Unique to African Haplotypes
    J. Noble, Jameel Johnson, J. A. Lane, A. Valdés · 2013 · Diabetes
  7. Type 1 diabetes patients born to immigrants to Sweden increase their native diabetes risk and differ from Swedish patients in HLA types and islet autoantibodies
    Ahmed J. Delli, Bengt Lindblad, Annelie Carlsson, Gun Forsander, Sten Anders Ivarsson, Johnny Ludvigsson, Claude Marcus, Åke Lernmark, for the Better Diabetes Diagnosis (BDD) Study Group · 2010 · Pediatric Diabetes
  8. Risk Factors and Characteristics of Checkpoint Inhibitor–Associated Autoimmune Diabetes Mellitus (CIADM): A Systematic Review and Delineation From Type 1 Diabetes
    Linda Wu, Venessa Tsang, Alexander Maxwell Menzies, Sarah Christina Sasson, Matteo Salvatore Carlino, David Alexander Brown, Roderick John Clifton-Bligh, Jenny Elizabeth Gunton · 2023 · Diabetes Care
  9. Molecular Signatures Differentiate Immune States in Type 1 Diabetic Families
    Yi-Guang Chen, Susanne M Cabrera, S. Jia, M. Kaldunski, J. Kramer, Sami Cheong, R. Geoffrey, Mark F. Roethle, J. Woodliff, C. Greenbaum et al. · 2014 · Diabetes
  10. High-Density SNP Mapping of the HLA Region Identifies Multiple Independent Susceptibility Loci Associated with Selective IgA Deficiency
    Ricardo C. Ferreira, Qiang Pan‐Hammarström, Robert Graham, Gumersindo Fontán, Annette T. Lee, Ward A. Ortmann, Ning Wang, Elena Urcelay, Miguel Fernández‐Arquero, Concepción Núñez et al. · 2012 · PLoS Genetics
  11. The pathogenic role of autoantibodies in recurrent pregnancy loss
    Silvia D’Ippolito, Carlo Ticconi, Chiara Tersigni, Serafina Garofalo, Carmelinda Martino, Antonio Lanzone, Giovanni Scambia, Nicoletta Di Simone · 2019 · American Journal of Reproductive Immunology
  12. Update of Type 1 Diabetes
    M. Jahromi · 2013
  13. Antigen Presentation in the Autoimmune Diabetes of the NOD Mouse
    Unanue, Emil R. · 2014 · Annual Review of Immunology
  14. Increasing accuracy of HLA imputation by a population-specific reference panel in a FinnGen biobank cohort
    J. Ritari, K. Hyvärinen, J. Clancy, J. Partanen, S. Koskela · 2020 · NAR Genomics and Bioinformatics
  15. Type 1 diabetes susceptibility alleles are associated with distinct alterations in the gut microbiota
    Jane Adair Mullaney, Juliette E. Stephens, Mary‐Ellen Costello, Cai Fong, Brooke E. Geeling, Patrick G. Gavin, Casey Maree Wright, Tim D. Spector, Matthew Arthur Brown, Emma E. Hamilton‐Williams · 2018 · Microbiome
  16. Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes
    Lue Ping Zhao, Shehab Alshiekh, Michael A. Zhao, Annelie Carlsson, Helena Elding Larsson, Gun Forsander, Sten Anders Ivarsson, Johnny Ludvigsson, Ingrid Skelton Kockum, Claude Marcus et al. · 2016 · Diabetes
  17. Management of diabetes mellitus in infants
    Beate Karges, Thomas Meißner, Andrea Icks, Thomas Michael Kapellen, Reinhard Walter Holl · 2011 · Nature Reviews Endocrinology
  18. Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes: Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S.
    Vibha Anand, Ying Li, Bin Liu, Mohamed F. Ghalwash, Eileen Koski, Kenney Ng, Jessica L. Dunne, Josefine Jönsson, Christiane Winkler, Mikael Knip et al. · 2021 · Diabetes Care
  19. Phases of type 1 diabetes in children and adolescents
    Jennifer Couper, Michael J. Haller, AG Ziegler, Mikael Knip, Johnny Ludvigsson, Maria E. Craig · 2014 · Pediatric Diabetes
  20. Stepwise or Linear Decrease in Penetrance of Type 1 Diabetes With Lower-Risk HLA Genotypes Over the Past 40 Years
    Steck, Andrea K., Armstrong, Taylor K., Babu, Sunanda R., Eisenbarth, George S., the Type 1 Diabetes Genetics Consortium · 2011 · Diabetes
  21. Epigenetic modification and therapeutic targets of diabetes mellitus
    Rajveer Singh, Shivani Chandel, Dhritiman Dey, Arijit Ghosh, Syamal Roy, V. Ravichandiran, Dipanjan Ghosh · 2020 · Bioscience Reports
  22. The Genetic Contribution to Type 1 Diabetes
    Marina A. Bakay, Rahul Pandey, Struan F.A. Grant, Hakon H. Hakonarson · 2019 · Current Diabetes Reports
  23. A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes.
    A. Ataie-Jafari, S. Loke, A. Rahmat, B. Larijani, F. Abbasi, M. Leow, Z. Yassin · 2013 · Clinical Nutrition
  24. The genetic architecture of type 1 diabetes mellitus
    Denis M. Nyaga, Mark Hedley Vickers, Craig Jefferies, Jo Kate Perry, Justin Martin O'Sullivan · 2018 · Molecular and Cellular Endocrinology
  25. Monoclonal antibody blocking the recognition of an insulin peptide–MHC complex modulates type 1 diabetes
    Li Zhang, F. Crawford, Li-Ping Yu, A. Michels, M. Nakayama, H. Davidson, J. Kappler, G. Eisenbarth · 2014 · Proceedings of the National Academy of Sciences of the United States of America
  26. Type 1 diabetes: primary antigen/peptide/register/trimolecular complex
    T. Sosinowski, George S. Eisenbarth · 2012 · Immunologic research
  27. The epidemiology of type 1 diabetes mellitus in older adults
    Tomic, Dunya, Harding, Jessica L., Jenkins, Alicia J., Shaw, Jonathan E., Magliano, Dianna J. · 2025 · Nature Reviews Endocrinology
  28. Association of HLA-dependent islet autoimmunity with systemic antibody responses to intestinal commensal bacteria in children
    Alexandra Paun, Christopher Yau, Shahab Meshkibaf, Michelle C. Daigneault, Leili Marandi, Steven M. Mortin-Toth, Amit Bar‐Or, Emma Allen‐Vercoe, Philippe Poussier, Jayne S. Danska · 2019 · Science Immunology
  29. HLA, PTPN22 and PD-1 associations as markers of autoimmunity in neuromyelitis optica
    N. Asgari, C. Nielsen, E. Stenager, K. Kyvik, S. Lillevang · 2012 · Multiple Sclerosis
  30. High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease
    Darja Smigoc Schweiger, A. Mendez, Sabina Kunilo Jamnik, N. Bratanič, N. Bratina, T. Battelino, J. Brecelj, B. Vidan-Jeras · 2016 · Autoimmunity
  31. Autoimmunity and the pathogenesis of type 1 diabetes
    Thomas R. Csorba, Andrew William Lyon, Morley Donald Hollenberg · 2010 · Critical Reviews in Clinical Laboratory Sciences
  32. Large-Scale Whole-Genome Sequencing Reveals the Genetic Architecture of Primary Membranoproliferative GN and C3 Glomerulopathy
    Adam P. Levine, Melanie Chan, Omid Sadeghi‐Alavijeh, Edwin Kwan Soon Wong, H. Terence Cook, Sofie E. Ashford, Keren Carss, Martin T. Christian, Matthew Hall, Claire Louise Harris et al. · 2020 · Journal of the American Society of Nephrology
  33. Hypomethylation within gene promoter regions and type 1 diabetes in discordant monozygotic twins
    Emon Elboudwarej, Michael B. Cole, Farren B. S. Briggs, Alexandra Fouts, Pamela R. Fain, Hong Quach, Diana L. Quach, Elizabeth Sinclair, Lindsey A. Criswell, Julie A. Lane et al. · 2016 · Journal of Autoimmunity
  34. Methods, quality control and specimen management in an international multicentre investigation of type 1 diabetes: TEDDY
    Kendra Vehik, Steven Fiske, Chad A. Logan, Daniel Agardh, Corrado Cilio, William Hagopian, Olli Simell, Merja Roivainen, Jin‐Xiong She, Thomas Briese et al. · 2013 · Diabetes/Metabolism Research and Reviews
  35. Genetic Epidemiology of Type 1 Diabetes in the 22 Arab Countries
    Hatem Zayed · 2016 · Current Diabetes Reports
  36. Genetics of onset of asthma
    F. Nicole Dijk, Johan C. de Jongste, Dirkje Sjoukje Postma, Gerard H. Koppelman · 2013 · Current Opinion in Allergy and Clinical Immunology
  37. Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome.
    K. Lima, T. Abrahamsen, A. B. Wolff, E. Husebye, M. Alimohammadi, O. Kämpe, I. Følling · 2011 · European Journal of Endocrinology
  38. The β Cell in Diabetes: Integrating Biomarkers With Functional Measures
    Steven E. Kahn, Yi‐Chun Chen, Nathalie Esser, Austin J. Taylor, Daniël H. van Raalte, Sakeneh Zraika, C. Bruce Verchere · 2021 · Endocrine Reviews
  39. A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance
    Jeremy T. Warshauer, Julia A. Belk, Alice Y. K. Chan, Jiaxi Wang, Alexander R. Gupta, Quanming Shi, Nikolaos Skartsis, Yani Peng, Jonah D. Phipps, Dante Dennis Acenas II et al. · 2021 · The Journal of Experimental Medicine
  40. Type 1 diabetes mellitus and multiple sclerosis: common etiological features
    Adam E. Handel, Lahiru Handunnetthi, George C. Ebers, Sreeram V Ramagopalan · 2009 · Nature Reviews Endocrinology
  41. Extreme genetic risk for type 1A diabetes in the post-genome era
    Erin E. Baschal, George S. Eisenbarth · 2008 · Journal of Autoimmunity
  42. Role of B Lymphocytes in the Pathogenesis of Type 1 Diabetes
    R. Hinman, J. Cambier · 2014 · Current Diabetes Reports
  43. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP)
    Nathali Kaushansky, Daniel Martin Altmann, Chella S. David, Hans Lassmann, Avraham Ben‐Nun · 2012 · Journal of Neuroinflammation
  44. Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors
    Shintaro Iwama, Tomoko Kobayashi, Hiroshi Arima · 2025 · Nature Reviews Endocrinology
  45. HLA-DQA1 and HLA-DQB1 Alleles, Conferring Susceptibility to Celiac Disease and Type 1 Diabetes, Are More Expressed Than Non-Predisposing Alleles and Are Coordinately Regulated
    Federica Farina, S. Picascia, L. Pisapia, P. Barba, S. Vitale, A. Franzese, E. Mozzillo, C. Gianfrani, Giovanna Del Pozzo G · 2019 · Cells
  46. Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment
    Brittney N. Newby, Clayton E. Mathews · 2017 · Frontiers in Endocrinology
  47. Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies
    Peggy Sekula, Yong Li, Horia C. Stanescu, Matthias Wuttke, Arif Bülent Ekici, Detlef Böckenhauer, Gerd Walz, Stephen H. Powis, Jan Thomas Kielstein, Paul E. Brenchley et al. · 2016 · Nephrology Dialysis Transplantation
  48. Introduction to ISPAD Clinical Practice Consensus Guidelines 2014 Compendium
    Carlo L. Acerini, Maria E. Craig, Carine E. de Beaufort, David M. Maahs, Ragnar Hanås · 2014 · Pediatric Diabetes
  49. Next Generation Sequencing Reveals the Association of DRB3*02:02 With Type 1 Diabetes
    H. Erlich, A. Valdés, Shana McDevitt, B. Simen, L. Blake, Kim R. McGowan, J. Todd, S. Rich, J. Noble · 2013 · Diabetes
  50. Cell type–specific immune phenotypes predict loss of insulin secretion in new-onset type 1 diabetes
    Matthew J. Dufort, Carla J. Greenbaum, Cate Speake, Peter S. Linsley · 2019 · JCI Insight
  51. Emerging Applications of Metabolomic and Genomic Profiling in Diabetic Clinical Medicine
    Aine M. McKillop, Peter R. Flatt · 2011 · Diabetes Care
  52. Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis
    MARIA JOSE REDONDO, Richard A. Oram, Andrea K. Steck · 2017 · Current Diabetes Reports
  53. Challenges in diagnosis and management of diabetes in the young
    R. Unnikrishnan, Viral N. Shah, V. Mohan · 2016 · Clinical Diabetes and Endocrinology
  54. The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants
    for the Type 1 Diabetes TrialNet Study Group, Farah A. Meah, Linda Anne DiMeglio, Carla J. Greenbaum, Janice S. Blum, Jay M. Sosenko, Alberto Pugliese, Susan Michelle Geyer, Ping Xu, Carmella Evans‐Molina · 2016 · Diabetologia
  55. Immune intervention in type 1 diabetes
    Michels, Aaron W., Eisenbarth, George S. · 2011 · Seminars in Immunology
  56. T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency.
    E. Bratland, Beate Skinningsrud, D. Undlien, E. Mozes, E. Husebye · 2009 · Journal of Clinical Endocrinology and Metabolism
  57. Decoding the immune dance: Unraveling the interplay between beta cells and type 1 diabetes
    Saptarshi Roy, Pravil Pokharel, Jon D. Piganelli · 2024 · Molecular Metabolism
  58. Machine learning reveals limited contribution of trans-only encoded variants to the HLA-DQ immunopeptidome
    J. B. Nilsson, S. Kaabinejadian, Hooman Yari, Bjoern Peters, C. Barra, L. Gragert, W. Hildebrand, M. Nielsen · 2023 · bioRxiv
  59. T Cell-Mediated Chronic Inflammatory Diseases Are Candidates for Therapeutic Tolerance Induction with Heat Shock Proteins
    Ariana Barbera Betancourt, Qingkang Lyu, F. Broere, A. Sijts, V. Rutten, W. van Eden · 2017 · Frontiers in Immunology
  60. Autoimmune polyendocrine syndrome type 1 (APS‐1) as a model for understanding autoimmune polyendocrine syndrome type 2 (APS‐2)
    Aaron W. Michels, George S. Eisenbarth · 2009 · Journal of Internal Medicine
  61. Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes
    David A. Ostrov, Aimon K. Alkanani, Kristen A. McDaniel, Stephanie R. Case, Erin E. Baschal, Laura L. Pyle, Sam Ellis, Bernadette Pöllinger, Katherine J. Seidl, Viral N. Shah et al. · 2018 · Journal of Clinical Investigation
  62. Using the T Cell Receptor as a Biomarker in Type 1 Diabetes
    Maki Nakayama, Aaron W. Michels · 2021 · Frontiers in Immunology
  63. Influence of PTPN22 Allotypes on Innate and Adaptive Immune Function in Health and Disease
    Lucas H. Armitage, Mark A. Wallet, Clayton E. Mathews · 2021 · Frontiers in Immunology
  64. Hybrid Insulin Peptides Are Recognized by Human T Cells in the Context of DRB1*04:01
    Ada Admin, David Arribas-Layton, Perrin Guyer, Thomas Delong, Mylinh Dang, I-Ting Chow, C. Speake, C. Greenbaum, W. Kwok, R. Baker et al. · 2020 · Diabetes
  65. miR-487a-3p upregulated in type 1 diabetes targets CTLA4 and FOXO3
    Magdalena Żurawek, Agnieszka Dzikiewicz‐Krawczyk, Katarzyna Iżykowska, Iwona Ziółkowska‐Suchanek, Bogda Skowrońska, Maria Czainska, Marta Podralska, Piotr Fichna, Grzegorz Krzysztof Przybylski, Marta Fichna et al. · 2018 · Diabetes Research and Clinical Practice
  66. Children With Islet Autoimmunity and Enterovirus Infection Demonstrate a Distinct Cytokine Profile
    Wing‐Chi G. Yeung, Ammira Al-Shabeeb, Chi Nam Ignatius Pang, Marc Ronald Wilkins, Jacki Catteau, Neville J. Howard, William D. Rawlinson, Maria E. Craig · 2012 · Diabetes
  67. Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule
    Menno van Lummel, Peter A. van Veelen, Arnoud H. de Ru, Jos Pool, Tatjana Nikolić, Sandra Laban, Antoinette M. Joosten, Jan Wouter Drijfhout, Iria Maria Gomez-Touriño, Sefina Arif et al. · 2015 · Diabetes
  68. Immunology of β-Cell Destruction
    Daria La Torre, Åke Lernmark · 2010 · Advances in experimental medicine and biology
  69. Regulation of inflammation in diabetes: From genetics to epigenomics evidence
    Marc Diedisheim, Elena Carcarino, Claire Vandiedonck, Ronan Roussel, Jean–François Gautier, Nicolas Venteclef · 2020 · Molecular Metabolism
  70. Checkpoint inhibitor-induced insulin-dependent diabetes: an emerging syndrome
    Ana Luisa Perdigoto, Zoe Quandt, Mark Stuart Anderson, Kevan C. Herold · 2019 · The Lancet Diabetes & Endocrinology
  71. Human leukocyte antigen polymorphisms and personalized medicine for rheumatoid arthritis
    H. Furukawa, Shomi Oka, K. Shimada, A. Hashimoto, S. Tohma · 2015 · Journal of Human Genetics
  72. New and future immunomodulatory therapy in type 1 diabetes
    James Tooley, Frank Waldron-Lynch, Kevan C. Herold · 2012 · Trends in Molecular Medicine
  73. Conditional meta-analysis stratifying on detailed HLA genotypes identifies a novel type 1 diabetes locus around TCF19 in the MHC
    Y. Cheung, J. Watkinson, D. Anastassiou · 2010 · Human Genetics
  74. Weak associations between human leucocyte antigen genotype and acute myocardial infarction
    H. Björkbacka, E. H. Lavant, G. N. Fredrikson, O. Melander, G. Berglund, J. Carlson, J. Nilsson · 2010 · Journal of Internal Medicine
  75. Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis.
    D. Karp, Nishanth Marthandan, S. G. Marsh, C. Ahn, F. Arnett, D. DeLuca, A. Diehl, R. Dunivin, K. Eilbeck, M. Feolo et al. · 2010 · Human Molecular Genetics
  76. A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies
    C. Strippel, Marisol Herrera-Rivero, M. Wendorff, Anja Tietz, F. Degenhardt, A. Witten, C. Schroeter, Christopher Nelke, Kristin S. Golombeck, Marie Madlener et al. · 2022 · Brain : a journal of neurology
  77. Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside
    Linda Wu, Venessa Tsang, Sarah Christina Sasson, Alexander Maxwell Menzies, Matteo Salvatore Carlino, David Alexander Brown, Roderick John Clifton-Bligh, Jenny Elizabeth Gunton · 2021 · Frontiers in Endocrinology
  78. Genetic Aspects of type 1 diabetes
    Hae Sang Lee, Jin Soon Hwang · 2019 · Annals of Pediatric Endocrinology & Metabolism
  79. Use of class I and class II HLA loci for predicting age at onset of type 1 diabetes in multiple populations
    A. Valdés, H. A. Erlich, Joyce Carlson, M. Varney, Priscilla V. Moonsamy, Janelle A. Noble · 2012 · Diabetologia
  80. Impact of Diabetes Susceptibility Loci on Progression From Pre-Diabetes to Diabetes in At-Risk Individuals of the Diabetes Prevention Trial–Type 1 (DPT-1)
    Vincent L. Butty, Christopher L. Campbell, Diane J. Mathis, Christophe O. Benoist, the DPT-1 Study Group · 2008 · Diabetes
  81. Diabetes and blood glucose disorders under anti-PD1
    Magis, Quentin, Gaudy-Marqueste, Caroline, Basire, Agnes, Loundou, Anderson, Malissen, Nausicaa, Troin, Laura, Monestier, Sandrine, Mallet, Stéphanie, Hesse, Sylvie, Richard, Marie-Aleth et al. · 2018 · Journal of Immunotherapy
  82. Type 1 Diabetes and the HLA Region: Genetic Association Besides Classical HLA Class II Genes
    Jana Sticht, Miguel Álvaro‐Benito, Stefan Konigorski · 2021 · Frontiers in Genetics
  83. PheMap: a multi-resource knowledge base for high-throughput phenotyping within electronic health records
    Neil S. Zheng, QiPing Feng, Vern Eric Kerchberger, Juan Zhao, Todd L. Edwards, Nancy Jean Cox, C Michael Stein, Dan M. Roden, Joshua C. Denny, W Wei · 2020 · Journal of the American Medical Informatics Association
  84. Maternal smoking during pregnancy and offspring type 1 diabetes mellitus risk: accounting for HLA haplotype
    K. Mattsson, I. Jönsson, E. Malmqvist, H. Larsson, L. Rylander · 2015 · European Journal of Epidemiology
  85. Environmental determinants of type 1 diabetes: A role for overweight and insulin resistance
    S. Islam, S. Srinivasan, M. E. Craig · 2014 · Journal of Paediatrics and Child Health
  86. Conditional Asymmetric Linkage Disequilibrium (ALD): Extending the Biallelic r2 Measure
    G. Thomson, R. Single · 2014 · Genetics
  87. B cells and type 1 diabetes …in mice and men
    R. Hinman, Mia J. Smith, J. Cambier · 2014 · Immunology Letters
  88. Fifty years of HLA-associated type 1 diabetes risk: history, current knowledge, and future directions
    Janelle Annette Noble · 2024 · Frontiers in Immunology
  89. A multi-ancestry genome-wide association study in type 1 diabetes
    Dominika A. Michalek, Courtney Tern, Wei Zhou, Catherine C. Robertson, Emily Farber, Paul Campolieto, Wei‐Min Chen, Suna Önengüt-Gümüşcü, Stephen S. Rich · 2024 · Human Molecular Genetics
  90. Coeliac disease in children with type 1 diabetes
    Kalle Kurppa, Anna Laitinen, Daniel Agardh · 2017 · The Lancet Child & Adolescent Health
  91. A case of fulminant Type 1 diabetes following anti-PD1 immunotherapy in a genetically susceptible patient.
    M. Araújo, D. Ligeiro, Luís Costa, F. Marques, H. Trindade, J. Correia, C. Fonseca · 2017 · Immunotherapy
  92. Assessment of CD4+ T Cell Responses to Glutamic Acid Decarboxylase 65 Using DQ8 Tetramers Reveals a Pathogenic Role of GAD65 121–140 and GAD65 250–266 in T1D Development
    I-Ting Chow, Junbao Yang, T. Gates, E. James, D. Mai, C. Greenbaum, W. Kwok · 2014 · PLoS ONE
  93. HLA-Class II in Latin American patients with type 1 diabetes.
    A. Rojas-Villarraga, Diana Botello-Corzo, J. Anaya · 2010 · Autoimmunity Reviews
  94. Family history of type 1 and type 2 diabetes and risk of latent autoimmune diabetes in adults (LADA)
    Rebecka Hjort, Lars S. Alfredsson, Tomas Andersson, Per‐Ola Carlsson, Valdemar Grill, Leif Groop, Mats Martinell, Bahareh Sadat Rasouli, Petter Storm, Jaakko Tuomilehto et al. · 2017 · Diabetes & Metabolism
  95. Association of 32 type 1 diabetes risk loci in Pakistani patients
    Aysha Karim Kiani, Peter C. L. John, Attya Bhatti, Asima Zia, Gulbin Shahid, Parveen Akhtar, Xingbin Wang, F. Yesim Demirci, M. Ilyas Kamboh · 2015 · Diabetes Research and Clinical Practice
  96. Low HERV-K(C4) Copy Number Is Associated With Type 1 Diabetes
    Michael Mason, C. Speake, V. Gersuk, Quynh-Anh Nguyen, Kimberly O'Brien, J. Odegard, J. Buckner, C. Greenbaum, D. Chaussabel, G. Nepom · 2014 · Diabetes
  97. HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX(®) B/E.
    R. Paris, S. Bejrachandra, P. Thongcharoen, S. Nitayaphan, P. Pitisuttithum, A. Sambor, S. Gurunathan, D. Francis, S. Ratto-Kim, C. Karnasuta et al. · 2012 · Vaccine
  98. Genetic and diabetic auto-antibody markers in Saudi children with type 1 diabetes.
    H. Manan, A. Angham, Awadalla Sitelbanat · 2010 · Human Immunology
  99. Several loci in the HLA class III region are associated with T1D risk after adjusting for DRB1-DQB1
    A. Valdés, Glenys Thomson · 2009 · Diabetes, obesity and metabolism
  100. Type 1 Diabetes: A Guide to Autoimmune Mechanisms for Clinicians
    François‐Xavier Mauvais, Peter Van Endert · 2025 · Diabetes Obesity and Metabolism